Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.63
-0.25 (-2.53%)
At close: Jun 18, 2026, 4:00 PM EDT
9.64
+0.01 (0.10%)
After-hours: Jun 18, 2026, 5:44 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $282.94 million as of June 18, 2026. Its market cap has increased by 14.27% in one year.
Market Cap
282.94M
Enterprise Value
176.16M
1-Year Change
14.27%
Ranking
Category
Stock Price
$9.63
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $282.94M, an increase of 70.38%. That is a compound annual growth rate of 22.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 282.94M | 50.91% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 280.75M |
| Bicycle Therapeutics | 278.55M |
| Niagen Bioscience | 270.56M |
| Immuneering | 267.85M |
| Eledon Pharmaceuticals | 265.92M |
| Surrozen | 264.72M |
| Neumora Therapeutics | 257.55M |
| Zentalis Pharmaceuticals | 252.71M |